NCT06409299View on ClinicalTrials.gov

Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

August 31, 2027

Conditions
TracheomalaciaBronchopulmonary Dysplasia (BPD)Vascular RingCystic Lung DiseaseBronchiectasisChronic Atelectasis
Interventions
DRUG

Azithromycin 40 MG/ML

Maintenance Antibiotic treatment

OTHER

Placebo

Placebo

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER